Clinical Trials Logo

Ovulation clinical trials

View clinical trials related to Ovulation.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06142097 Recruiting - Menstrual Cycle Clinical Trials

Sensor Technology Assessments of Reproductive Target Study

START
Start date: June 15, 2022
Phase:
Study type: Observational

The objective of this study was to better understand female reproductive health in the context of using wearable technology. Participants were provided and wore an Oura Ring, tracked their menstrual cycles, provided at-home ovulation test results, and had their cycles monitored via trans-vaginal ultrasounds. The study aimed to collect data from females with regular menstrual cycles.

NCT ID: NCT05999123 Recruiting - Menstruation Clinical Trials

Menstrual Cycle Study

Start date: July 25, 2023
Phase:
Study type: Observational

A data collection study to develop algorithms to estimate menstrual cycle phases.

NCT ID: NCT04196595 Recruiting - Infertility Clinical Trials

Apple Women's Health Study

Start date: November 14, 2019
Phase:
Study type: Observational

This is an observational longitudinal study to advance the understanding of menstrual cycle and gynecologic health conditions including PCOS, infertility and breast cancer.The study will be hosted within the Research app(available on App Store), which allows a user to find, enroll, and participate in Apple-supported health-related research studies.

NCT ID: NCT02571543 Recruiting - Pregnancy Clinical Trials

Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?

Ibudelay
Start date: January 2016
Phase: Phase 2
Study type: Interventional

During natural cycle in vitro fertilisation, no gonadotropin stimulation is used to stimulate oocyte production. Ovulation is induced with HCG (human chorionic gonadotropin) and the follicle is retrieved 36 hours later. In this study the patient in the intervention group will receive Ibuprofen as a study intervention beginning at the same time as the HCG injection. The treatment dose will either be 400mg every 8 to 12 hours or 800mg every 8 to 12 hours until the follicle retrieval, totalling 5 tablets. Instead of the usual time period of 36 hours, the follicular punction will occur after 42 hours. Should the oocyte still be accessible after this time period, then it is proven that Ibuprofen delays ovulation. In this case the patient will continue the regular NC-IVF treatment cycle. The study design is a admissible two-stage design. During stage 1, 8 cycles in 8 patients will be examined. Should it be the case that after these 8 patients have completed a cycle, 4 or more show a positive treatment effect from the Ibuprofen intake, then the study will continue to stage 2 with 17 more more patients, totalling 25. Should it be the case however, that after 8 patients, 3 or less show an effect of the Ibuprofen intake, then the study will be stopped prematurely for futility. The study intervention will be increased to 800mg of Ibuprofen and the study will recommence with 8 more patients. A control group will consist of women undergoing intrauterine insemination (IUI) or timed sexual intercourse (TSI). 42 hours after Beta-HCG injection, an ultrasound examination will be performed in order to determine the number of remaining follicles in the ovary. This examination is to verify and control the proposed time limit of 42 hours.